{"id":"W1942558153","doi":"10.1200/jco.2000.18.6.1193","title":"Oxaliplatin or Paclitaxel in Patients With Platinum-Pretreated Advanced Ovarian Cancer: A Randomized Phase II Study of the European Organization for Research and Treatment of Cancer Gynecology Group","year":2000,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":162,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"National Cancer Institute; World Health Organization","keywords":"Medicine; Oxaliplatin; Carboplatin; Ovarian cancer; Paclitaxel; Internal medicine; Neutropenia; Population; Cisplatin; Chemotherapy; Progression-free survival; Gynecologic oncology; Febrile neutropenia; Oncology; Cancer; Surgery; Colorectal cancer","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002836593,0.001063884,0.002431128,0.0004072479,0.0003306079,0.0006806899,0.0006573591,0.001259841,0.003321664],"category_scores_gemma":[0.002003575,0.0005696706,0.001123499,0.0004371762,0.001042573,0.0006191792,0.0004550115,0.002171467,0.0003465507],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000605823,"about_ca_system_score_gemma":0.001500448,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005585723,"about_ca_topic_score_gemma":0.0009595357,"domain_scores_codex":[0.9990546,0.0006427797,0.00005522482,0.00009961659,0.00006248782,0.00008516581],"domain_scores_gemma":[0.9987684,0.0003738576,0.0003154509,0.00008509497,0.00004625475,0.0004110663],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9476373,0.01783098,0.004475292,0.0003652601,0.0006863433,0.00007340223,0.0000757762,0.0005788979,0.003792407,0.00009159603,0.0006708499,0.02372193],"study_design_scores_gemma":[0.9199037,0.07599453,0.002742071,0.00001254504,0.0001986738,0.00004604839,0.00001181941,0.0002752588,0.000330199,0.0000488537,0.0004307134,0.000005633399],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9927073,0.001757582,0.0005105286,0.0003959673,0.0001929733,0.003532284,0.0002970093,0.00003213071,0.0005741722],"genre_scores_gemma":[0.9854404,0.002117554,0.002036096,0.001494167,0.0004521475,0.006224276,0.0009696638,0.00001801628,0.001247543],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003321664,"threshold_uncertainty_score":0.01500154,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1058041164294967,"score_gpt":0.4781313047964457,"score_spread":0.372327188366949,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}